Skip to main content
Transgene SA (EPA: TNG)
France flag France · Delayed Price · Currency is EUR
0.702
0.00 (0.00%)
Dec 20, 2024, 5:35 PM CET

Transgene Revenue

Transgene had revenue of 3.36M EUR in the half year ending June 30, 2024, a decrease of -44.85%. This brings the company's revenue in the last twelve months to 6.49M, down -28.00% year-over-year. In the year 2023, Transgene had annual revenue of 7.90M, down -23.63%.

Revenue (ttm)
6.49M
Revenue Growth
-28.00%
P/S Ratio
10.94
Revenue / Employee
44.48K
Employees
141
Market Cap
92.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 20209.57M-3.72M-28.00%
Dec 31, 201913.30M6.21M87.69%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sanofi 48.45B
EssilorLuxottica Société anonyme 25.83B
Sartorius Stedim Biotech S.A. 2.74B
bioMérieux S.A. 3.81B
Eurofins Scientific SE 6.72B
Ipsen S.A. 3.44B
Virbac SA 1.34B
Ramsay Générale de Santé SA 5.01B
Revenue Rankings

Transgene News

More News